Brief: Thor Medical H2 EBITDA Loss NOK 25.7 Mln
26/02/2026 06:43
Feb 26 (Reuters) - Thor Medical ASA TRMED.OL: H2 REVENUE NOK 0.8 MILLION VERSUS NOK 0 MILLION YEAR AGO H2 EBITDA NOK -25.7 MILLION VERSUS NOK -28.9 MILLION YEAR AGO Source text: ID:nObiYMGFza Further company coverage: TRMED.OL (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com;))
Recent news on Thor Medical ASA
See all newsBrief: Thor Medical Enters Partnership Agreement With Minerva Imaging
Brief: Thor Medical Partners With Eckert & Ziegler
Brief: Thor Medical Completes Alphaone Production Facility At Herøya Industrial Park
Brief: Thor Medical Enters Multiyear Agreement With Node Pharma
Brief: Thor Medical H2 EBITDA Loss NOK 25.7 Mln